Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.13.11.52 extracted from

  • Metz, R.; Duhadaway, J.B.; Kamasani, U.; Laury-Kleintop, L.; Muller, A.J.; Prendergast, G.C.
    Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan (2007), Cancer Res., 67, 7082-7087.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
1-methyl-D-tryptophan IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
dendritic cell expressed in antigen-presenting dendritic cells where tryptophan catabolism drives immune tolerance Homo sapiens
-

Synonyms

Synonyms Comment Organism
IDO2
-
Homo sapiens